LINC01714 Enhances Gemcitabine Sensitivity by Modulating FOXO3 Phosphorylation in Cholangiocarcinoma

Overview

Journal Mol Ther Nucleic Acids

Publisher Cell Press

Date 2020 Jan 7

PMID 31902744

Citations 15

Authors

Sheng Shen

Jiwen Wang

Bohao Zheng

Ying Tao

Min Li

Yueqi Wang

Xiaoling Ni

Tao Suo

Houbao Liu

Han Liu

Jiwei Zhang

Affiliations

Soon will be listed here.

Abstract

Long noncoding RNAs (lncRNAs) have been shown to play crucial roles in human cancers. However, the underlying biological functions and mechanisms of lncRNAs in cholangiocarcinoma (CCA) remain largely unknown. We aimed to characterize the transcriptional landscape of lncRNAs in CCA and identify lncRNAs that were able to serve as prognosis markers and therapeutic targets for CCA. Here, we investigated the transcriptional landscape and dysregulation of lncRNAs in CCA. LINC01714 was found to be recurrently downregulated in CCA tumor samples. Our results revealed that decreased LINC01714 expression was associated with the poor survival of CCA patients. Our observations revealed that LINC01714 suppressed the proliferation, migration, and invasion abilities of CCA cells both in vitro and in vivo. Furthermore, we found that LINC01714 physically interacted with Forkhead Box O3 (FOXO3) and increased the FOXO3 protein level. In addition, LINC01714 could decrease the phosphorylation level of FOXO3. Interestingly, LINC01714 was able to enhance the sensitivity to gemcitabine in CCA tumor cells through modulating phosphorylated FOXO3-Ser318. Our study revealed LINC01714 as a promising prognostic indictor for patients with CCA, provided insights into the molecular pathogenesis of CCA, and also showed that LINC01714 is a potential therapeutic combination for gemcitabine in CCA treatment.

Citing Articles

LINC00870 promotes imatinib resistance in gastrointestinal stromal tumor via inhibiting PIGR glycosylation modifications.

Li Y, Dai Z, Cheng Z, He J, Yin Y, Liu X Heliyon. 2025; 11(3):e41934.

PMID: 39968132 PMC: 11834037. DOI: 10.1016/j.heliyon.2025.e41934.

LncRNAs as nodes for the cross-talk between autophagy and Wnt signaling in pancreatic cancer drug resistance.

Huang Y, Zhang R, Lyu H, Xiao S, Guo D, Chen X Int J Biol Sci. 2024; 20(7):2698-2726.

PMID: 38725864 PMC: 11077374. DOI: 10.7150/ijbs.91832.

Non-coding RNA and Drug resistance in cholangiocarcinoma.

Wu Z, Jiang S, Chen Y Noncoding RNA Res. 2023; 9(1):194-202.

PMID: 38125756 PMC: 10730441. DOI: 10.1016/j.ncrna.2023.11.003.

Extracellular vesicle small RNA cargo discriminates non-cancer donors from pediatric B-lymphoblastic leukemia patients.

Longjohn M, Hudson J, Pena-Castillo L, Cormier R, Hannay B, Chacko S Front Oncol. 2023; 13:1272883.

PMID: 38023151 PMC: 10679349. DOI: 10.3389/fonc.2023.1272883.

Inhibition of XPO1 impairs cholangiocarcinoma cell proliferation by triggering p53 intranuclear accumulation.

Zhao C, Ma B, Yang Z, Li O, Liu S, Pan L Cancer Med. 2022; 12(5):5751-5763.

PMID: 36200270 PMC: 10028126. DOI: 10.1002/cam4.5322.

References

Engreitz J, Pandya-Jones A, McDonel P, Shishkin A, Sirokman K, Surka C . The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science. 2013; 341(6147):1237973. PMC: 3778663. DOI: 10.1126/science.1237973. View

Grossman R, Heath A, Ferretti V, Varmus H, Lowy D, Kibbe W . Toward a Shared Vision for Cancer Genomic Data. N Engl J Med. 2016; 375(12):1109-12. PMC: 6309165. DOI: 10.1056/NEJMp1607591. View

Trapnell C, Williams B, Pertea G, Mortazavi A, Kwan G, van Baren M . Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010; 28(5):511-5. PMC: 3146043. DOI: 10.1038/nbt.1621. View

Guan L, Zhang L, Gong Z, Hou X, Xu Y, Feng X . FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signaling. Hepatology. 2016; 63(6):1914-27. DOI: 10.1002/hep.28496. View

Xu M, Wang Y, Weng W, Wei P, Qi P, Zhang Q . A Positive Feedback Loop of lncRNA- and FOXM1 Facilitates Gastric Cancer Growth and Invasion. Clin Cancer Res. 2016; 23(8):2071-2080. DOI: 10.1158/1078-0432.CCR-16-0742. View

Shi X, Zhang H, Wang M, Xu X, Zhao Y, He R . LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells. Oncotarget. 2017; 8(35):58394-58404. PMC: 5601661. DOI: 10.18632/oncotarget.16880. View

Zhang J, Li Z, Liu L, Wang Q, Li S, Chen D . Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway. Hepatology. 2017; 67(1):171-187. DOI: 10.1002/hep.29405. View

Li Z, Zhang J, Liu X, Li S, Wang Q, Chen D . The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma. Nat Commun. 2018; 9(1):1572. PMC: 5910401. DOI: 10.1038/s41467-018-04006-0. View

Myatt S, Lam E . The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 2007; 7(11):847-59. DOI: 10.1038/nrc2223. View

10.

Ma Y, Yang Y, Wang F, Moyer M, Wei Q, Zhang P . Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of activator protein 2α. Gut. 2015; 65(9):1494-504. DOI: 10.1136/gutjnl-2014-308392. View

11.

Dobin A, Davis C, Schlesinger F, Drenkow J, Zaleski C, Jha S . STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012; 29(1):15-21. PMC: 3530905. DOI: 10.1093/bioinformatics/bts635. View

12.

Marchese F, Raimondi I, Huarte M . The multidimensional mechanisms of long noncoding RNA function. Genome Biol. 2017; 18(1):206. PMC: 5663108. DOI: 10.1186/s13059-017-1348-2. View

13.

Blechacz B, Gores G . Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology. 2008; 48(1):308-21. PMC: 2547491. DOI: 10.1002/hep.22310. View

14.

Bian Z, Zhang J, Li M, Feng Y, Wang X, Zhang J . LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling. Clin Cancer Res. 2018; 24(19):4808-4819. DOI: 10.1158/1078-0432.CCR-17-2967. View

15.

Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

16.

Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

17.

Razumilava N, Gores G . Cholangiocarcinoma. Lancet. 2014; 383(9935):2168-79. PMC: 4069226. DOI: 10.1016/S0140-6736(13)61903-0. View

18.

Park J, Oh D, Hsu C, Chen J, Chen L, Orlando M . Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review. Cancer Res Treat. 2015; 47(3):343-61. PMC: 4509359. DOI: 10.4143/crt.2014.308. View

19.

Gatto M, Bragazzi M, Semeraro R, Napoli C, Gentile R, Torrice A . Cholangiocarcinoma: update and future perspectives. Dig Liver Dis. 2010; 42(4):253-60. DOI: 10.1016/j.dld.2009.12.008. View

20.

Liu Y, Ao X, Ding W, Ponnusamy M, Wu W, Hao X . Critical role of FOXO3a in carcinogenesis. Mol Cancer. 2018; 17(1):104. PMC: 6060507. DOI: 10.1186/s12943-018-0856-3. View